While nonmutated germline variable region (V) genes have been found to encode heavy or light chains of various human autoantibodies, the use of germline V genes by both chains of a given autoantibody has not been documented. Recently, we reported that the heavy chain V gene (designated Humha346) of the Kim4.6 anti-DNA antibody is identical to a germline VH gene, 1.9111. To investigate whether this autoantibody was entirely germline encoded, we searched for the germline counterpart to the Kim4.6 VX segment (designated Humlal46) and isolated a VXI gene designated Humlvll7, which was identical to Humlal46. Together with the sequence identity of the Kim4.6/Humha346 and 1.9111 VH genes, the current data provide the first direct proof that an autoantibody can be encoded entirely by germline V genes without any somatic change. In addition, Humlvll7 is the first VXI germline gene that has been isolated, and is highly homologous to the VX genes expressed in two lymphomas. Thus, this VXI gene should provide a useful tool for investigating the expression of the human VX gene repertoire, particularly with regard to autoimmune and/or lymphoproliferative diseases.
Introduction
During the past few years, there has been major progress in the elucidation of the genetic mechanisms for antibody production as they relate to many antigen-specific immune responses (1) (2) (3) . Until recently, however, little information has been available with regard to the genetic basis of specific autoimmune responses, and in particular, the contribution of variable region (V)1 genes and somatic mutation to the generation of such responses. From studies in many laboratories it has been shown that there is frequent sharing of crossreactive idiotypes among human autoantibodies of given specificities, implying that they use the same or similar germline V genes with little somatic change (4) (5) (6) . This interpretation is supported by the finding ofextensive similarity among the heavy and light chain V regions of idiotypically related monoclonal autoantibodies (7, 8) , and more recently by data showing complete identity between a germline VK gene (Humkv325) and four human rheumatoid factor light chains (9, 10) . However, whether antibodies reactive with self-antigens can be encoded by heavy and light chain germline V genes that are both unaltered by somatic mutation remains unclear.
Among the various human autoantibodies, anti-DNA antibodies have been a particular object of investigation, originally in the context of their strong association with systemic lupus erythematosus (SLE) and, more recently, with regard to their occurrence in apparently healthy individuals (5) . To investigate the genetic origins of this autoimmune response, we undertook studies of V gene utilization in "natural" anti-DNA antibodies derived from nonautoimmune subjects. Included among these was an IgMX anti-DNA monoclonal antibody (designated Kim4.6), derived from nonautoimmune tonsillar lymphoid cells and reactive with both single-and double-stranded DNA, synthetic polynucleotides, RNA and cardiolipin (11) . As previously reported, this autoantibody uses a heavy chain V (VH) gene identical in sequence to a germline VH gene, 1.91II (12, 13) . Although the sequence of the Kim4.6 lambda light chain V (VX) gene (Humlal46) was also determined, its relationship to the germline gene repertoire could not be assessed since very few data were available with regard to human germline VX gene sequences. Similarly, while the use of nonmutated germline VH genes has been reported for several human monoclonal autoantibodies derived from SLE patients, as for the Kim4.6 antibody, the concomitant expression of nonmutated light chain V genes in these antibodies has not been documented (14) (15) (16) (9, 10) . In addition, expression of Humkv325 was found in 20% of human chronic lymphocytic leukemias, a tumor arising from the autoreactive CD5 B cell subset (23, 24) . These data raise the possibility that other autoantibody-associated V genes, such as Humlv 117, might also be used preferentially by paraproteins that exhibit autoreactivity, and be expressed frequently in malignant B cells. In this regard, it is noteworthy that Humlv 117 is highly homologous to the single V nucleotide sequence that has been reported for VXI-secreting Burkitt lymphomas as well as a VX segment recently isolated from a diffuse large cell lymphoma line (Figs. I and 2) (21, 22) . In addition, Humlv 1 17 displays > 90% amino acid sequence homology with five previously published VXI paraproteins (Fig. 2) (25) . 11 other paraproteins assigned to the XI subgroup share a lesser degree of homology with Humlv 117 and are likely to be encoded by other germline genes and represent a distinct VXI sub-subgroup as suggested previously (26). The only other human germline VX gene that has been previously cloned and sequenced (termed 4A) displayed < 50% amino acid sequence similarity to any of the lambda light chain sequences from all six VX subgroups defined by amino acid sequence comparisons (25, 27 "Llhuzm" is a temporary designation for the light chain designated A29700 in the NBRF database. Except for T2/C5, a recently reported VX gene (22) . the remaining sequences are from "Sequences of proteins of immunological interest" (25) . We bodies, which are generally of the IgM isotype, polyspecific, and idiotypically crossreactive, are representative of early ontogenic or primary immune responses (5, 28, 29) . Similarly, the VH gene of another human anti-DNA antibody (18/2) is identical in sequence with a germline VH gene, VH26, and the VH gene encoding an anti-Sm antibody (4B4) displays sequence identity with that of a fetal liver cDNA (20P1/M26) derived from a different individual, suggesting the latter two sequences also represent nonmutated forms of a germline gene (14) (15) (16) 30) . By contrast, the properties ascribed to "pathogenic" autoantibodies, IgG isotype, fine specificity, and high affinity, are characteristic of the somatically mutated antibodies associated with secondary immune responses (6, 31, 32) . Extensive somatic diversification has, in fact, been found among the IgG autoantibodies of autoimmune mice and appears to correlate with the development of high affinity autoantibodies (31, 32) . Taken together, these results suggest that autoimmune responses use the same molecular mechanisms of diversification found in non-self antigen-driven responses, and that their utilization ofgermline or somatically mutated V genes is likely to reflect the developmental stage and immunologic context in which the response originates.
Finally, it is noteworthy that two previously sequenced autoantibodies, the 18/2 anti-DNA and 4B4 anti-Sm antibodies, use germline VH genes identical with VH genes that appear to be preferentially expressed in the fetal pre-B cell repertoire (14, 16, 30) . Similarly, the VH gene encoding the Kim4.6 autoantibody belongs to the restricted set of VH genes expressed among fetal liver B cells ( 12, 30) . It therefore appears likely that autoreactive antibodies are relevant to the development and maintenance of the normal immune repertoire, and it is plausible that an abnormal expansion and diversification of the natural preimmune repertoire may be related to the appearance of "pathogenic" autoantibodies associated with autoimmune disease.
